Navigation Links
Pacific Shore Holdings, Inc. Receives Symbol Change Approval From FINRA
Date:2/14/2011

LOS ANGELES, Feb 14, 2011 /PRNewswire/ -- Pacific Shore Holdings, Inc. (previously Green Shores, Inc.), a Delaware corporation, announced today that management has received approval from the Financial Industry Regulatory Authority ("FINRA") for the change of its symbol to "PSHR.PK" from "GSHR.PK". "We are excited about the symbol change, as it takes us one step closer to completion of our planned entrance into the Public Markets. "Once we enter the Public Marketplace, we believe that we will be in position to attract significant capital infusions from a multitude of Market players," states Pacific Shore Holdings, Inc. Chief Financial Officer Ronald J. Tchorzewski.

Building on its corporate governance, Pacific Shore Holdings, Inc. also announced today that it has appointed Matthew A. Mills as Chairman of the Board, President and Chief Executive Officer of the Company replacing Dr. David E. Toomey who will remain as a Director of the Company as well as Executive Vice President. In addition, Mr. Mills announced the appointments of Ronald J. Tchorzewski as Chief Financial Officer and Director, Jennifer Mills as Corporate Secretary and Director and Dr. Allan Kurtz as a Director. "I am pleased with these appointments as each individual brings with them valuable experience and expertise to help take our Company to the next level. Our multiple brands and products have shown a very positive response from consumers around the world during our test marketing programs. I believe we will now be poised to secure the financial resources necessary to begin aggressive product marketing campaigns nationally and internationally to successfully expand our operations," states President and Chief Executive Officer Matthew Mills.

About Pacific Shore Holdings, Inc.: Pacific Shore Holdings, Inc. is a Delaware corporation whose dormant common stock has a trading symbol on the Pink Sheets of "PSHR.PK" which was previously "GSHR.PK". For more information, contact Pacific Shore Holdings, Inc. at info@pac-sh.com or (818) 998-0996.

Forward-Looking Statements: Certain statements in this press release are forward-looking in nature (within the meaning of the Private Securities Litigation Reform Act of 1995) and accordingly, are subject to risks and uncertainties. The actual results may differ materially from those described or contemplated and consequently, you should not rely on these forward-looking statements as predictions of future events.


'/>"/>
SOURCE Pacific Shore Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Pacific Biosciences and Harvard scientists decode genome of Haitian cholera pathogen
2. Asia Pacific Flexible Alternating Current Transmission Equipment Markets
3. BioProcess International Launches Monthly Asia-Pacific eNewsletter
4. Sundia Named Deloitte Technology Fast 500 Asia Pacific for 2nd Consecutive Year
5. OncoGenex Pharmaceuticals CEO Named Canadas Pacific Ernst & Youngs Entrepreneur Of The Year(R) in the Health Sciences Category
6. Hugh Tilson Receives Leadership Award at Pacific Drug Safety Summit
7. Pacific Biometrics Completes $4 Million Debt Financing
8. Pacific Health Research Institute Awarded $2.8 Million in Research Funding
9. Pacific Health Research Institute Awarded $2.8 Million in Research Funding
10. PacificGMP and USC to Collaborate on Recombinant Protein Development and Manufacturing for Phase 1 Clinical Trial
11. Avantium to Deliver Flowrence System to Pacific Northwest National Laboratory (PNNL), USA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... TX (PRWEB) , ... October 11, 2017 , ... ... August compared the implantation and pregnancy rates in frozen and fresh in ... contribution of progesterone and maternal age to IVF success. , After comparing the ...
(Date:10/10/2017)... ... 2017 , ... Dr. Bob Harman, founder and CEO of VetStem Biopharma, ... The event entitled “Stem Cells and Their Regenerative Powers,” was held on ... DVM, MPVM was joined by two human doctors: Peter B. Hanson, M.D., Chief of ...
(Date:10/9/2017)... , Oct. 9, 2017  BioTech Holdings ... mechanism by which its ProCell stem cell therapy ... limb ischemia.  The Company, demonstrated that treatment with ... of limbs saved as compared to standard bone ... molecule HGF resulted in reduction of therapeutic effect.  ...
(Date:10/7/2017)... ... October 06, 2017 , ... ... applications consulting for microscopy and surface analysis, Nanoscience Instruments is now expanding ... offers a broad range of contract analysis services for advanced applications. Services ...
Breaking Biology Technology:
(Date:4/5/2017)... SEATTLE , April 5, 2017  The Allen ... the Allen Cell Explorer: a one-of-a-kind portal and dynamic ... large-scale 3D imaging data, the first application of deep ... edited human stem cell lines and a growing suite ... the platform for these and future publicly available resources ...
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
(Date:3/29/2017)... -- higi, the health IT company that operates the largest ... , today announced a Series B investment from BlueCross ... new investment and acquisition accelerates higi,s strategy to create ... health activities through the collection and workflow integration of ... and secures data today on behalf of over 36 ...
Breaking Biology News(10 mins):